Dr Reddys Laboratories Ltd
Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:	500124	NSE Symbol:	DRREDDY	P/E :	19.34
ISIN Demat:	INE089A01031	Div & Yield %:	0.67	EPS :	62.12
Book Value:	322.46	Market Cap (Rs. Cr.):	100,255.64	Face Value :	1

Date	Headline
24-Mar-25	Dr Reddys announces cessation of subsidiary in Louisiana
22-Mar-25	Dr Reddys Laboratories to conduct board meeting
13-Mar-25	Dr. Reddy's recalls Levetiracetam in 0.75% Sodium Chloride Injection 1,000 mg/100 mL in US
06-Mar-25	Dr Reddys Laboratories allots 11,250 equity shares under ESOS
14-Feb-25	Dr Reddys Laboratories allots 20,155 equity shares under ESOS
27-Dec-24	Dr Reddys Laboratories receives affirmation in credit ratings for bank facilities
24-Dec-24	Dr Reddys Laboratories to convene board meeting
20-Dec-24	Dr Reddys Laboratories allots 13,080 equity shares under ESOS
28-Nov-24	Dr Reddys launches immuno-oncology drug - Toripalimab in India
14-Nov-24	Mexican health regulator imposes penalty on Dr Reddy's

Company Snapshot